PERSONALIZED MEDICINE COALITION for PERSONALIZED MEDICINE COALITION
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Congressional Personalized Medicine Caucus Genetic Testing and Genomic Sequencing for Rare Diseases H.R. 2471 Right Drug Dose Now Act H.R. 6208/S. 3607 Access to Genetic Counseling Services Act H.R. 3514 / S. 1816 Improving Seniors Timely Access to Care Act H.R. 5269/S. 2761Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act H.R. 1672 Maintaining Investments in New Innovation Act S. 832 Ensuring Pathways to Innovative Cures Act of 2025 Implementation of the Medicare Drug Price Negotiation (Public Law 117-169) Implementation of Rural Health Transformation Program (Public Law 119-21) Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) Collaborative Community
| Lobbyist | Covered position, as disclosed |
|---|---|
| CYNTHIA BENS | Staff, Representative Paul E. Kanjorski |
Budget/Appropriations BUD
FY 2026 Food and Drug Administration Budget Priorities for CDER, CBER and CDRH FY 2026 National Institutes of Health Budget Priorities Reauthorization of the Prescription Drug User Fee Act; PFUFA VIII Reauthorization of the Medical Device User Fee Act; MDUFA VI
| Lobbyist | Covered position, as disclosed |
|---|---|
| CYNTHIA BENS | Staff, Representative Paul E. Kanjorski |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.